The clinical characteristics of autosomal dominant tubulointerstitial kidney disease (ADTKD) include bland urinary sediment, slowly progressive chronic kidney disease (CKD) with many patients reaching end stage renal disease (ESRD) between age 20 and 70 years, and autosomal dominant inheritance. Due to advances in genetic diagnosis, ADTKD is becoming increasingly recognized as a cause of CKD. Pathogenic variants in UMOD, MUC1, and REN are the most common causes of ADTKD. ADTKD-UMOD is also associated with hyperuricemia and gout. ADTKD-REN often presents in childhood with mild hypotension, CKD, hyperkalemia, acidosis, and anemia. ADTKD-MUC1 patients present only with CKD. This review describes the pathophysiology, genetics, clinical manifestation, and diagnosis for ADTKD, with an emphasis on genetic testing and genetic counseling suggestions for patients.

Research Unit of Rare Diseases Department of Paediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University Prague Czech Republic

Wake Forest University School of Medicine Section on Nephrology Winston Salem North Carolina USA

Zobrazit více v PubMed

Adalat, S. , Woolf, A. S. , Johnstone, K. A. , Wirsing, A. , Harries, L. W. , Long, D. A. , … Bockenhauer, D. (2009). HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. Journal of the American Society of Nephrology, 20(5), 1123–1131. 10.1681/ASN.2008060633 PubMed DOI PMC

Armenta, A. , Madero, M. , & Rodriguez‐Iturbe, B. (2022). Functional Reserve of the Kidney. Clinical Journal of the American Society of Nephrology, 17(3), 458–466. 10.2215/CJN.11070821 PubMed DOI PMC

Ballester, B. , Milara, J. , & Cortijo, J. (2021). The role of mucin 1 in respiratory diseases. European Respiratory Review, 30(159), 200149. 10.1183/16000617.0149-2020 PubMed DOI PMC

Bellanne‐Chantelot, C. , Chauveau, D. , Gautier, J. F. , Dubois‐Laforgue, D. , Clauin, S. , Beaufils, S. , … Timsit, J. (2004). Clinical spectrum associated with hepatocyte nuclear factor‐1beta mutations. Annals of Internal Medicine, 140(7), 510–517. PubMed

Bernascone, I. , Vavassori, S. , Di, P. A. , Santambrogio, S. , Lamorte, G. , Amoroso, A. , … Rampoldi, L. (2006). Defective intracellular trafficking of uromodulin mutant isoforms. Traffic, 7(11), 1567–1579. 10.1111/j.1600-0854.2006.00481.x PubMed DOI

Biering, S. B. , Sarnik, S. A. , Wang, E. , Zengel, J. R. , Leist, S. R. , Schafer, A. , … Hsu, P. D. (2022). Genome‐wide bidirectional CRISPR screens identify mucins as host factors modulating SARS‐CoV‐2 infection. Nature Genetics, 54(8), 1078–1089. 10.1038/s41588-022-01131-x PubMed DOI PMC

Bleyer, A. , Westemeyer, M. , Xie, J. , Bloom, M. , Brossart, K. , Eckel, J. , … McKanna, T. (2022). Genetic etiologies for chronic kidney disease revealed through next‐generation renal gene panel. American Journal of Nephrology, 53(4), 297–306. 10.1159/000522226 PubMed DOI PMC

Bleyer, A. J. , Kidd, K. , Johnson, E. , Robins, V. , Martin, L. , Taylor, A. , … Kmoch, S. (2019). Quality of life in patients with autosomal dominant tubulointerstitial kidney disease. Clinical Nephrology, 92(6), 302–311. 10.5414/CN109842 PubMed DOI

Bleyer, A. J. , Kidd, K. , Robins, V. , Martin, L. , Taylor, A. , Santi, A. , … Kmoch, S. (2019). Outcomes of patient self‐referral for the diagnosis of several rare inherited kidney diseases. Genetics in Medicine, 22, 142–149. 10.1038/s41436-019-0617-8 PubMed DOI PMC

Bleyer, A. J. , Kidd, K. , Zivna, M. , & Kmoch, S. (2017). Autosomal dominant Tubulointerstitial kidney disease. Advances in Chronic Kidney Disease, 24(2), 86–93. 10.1053/j.ackd.2016.11.012 PubMed DOI PMC

Bleyer, A. J. , & Kmoch, S. (1993). Autosomal Dominant Tubulointerstitial Kidney Disease, MUC1‐Related. https://www.ncbi.nlm.nih.gov/books/NBK153723/. PubMed

Bleyer, A. J. , & Kmoch, S. (2020). The varied clinical presentation of autosomal dominant Tubulointerstitial kidney disease due to HNF1beta mutations. Kidney International Reports, 5(12), 2133–2135. 10.1016/j.ekir.2020.10.008 PubMed DOI PMC

Bleyer, A. J. , Kmoch, S. , Antignac, C. , Robins, V. , Kidd, K. , Kelsoe, J. R. , … Hart, P. S. (2014). Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clinical Journal of the American Society of Nephrology, 9(3), 527–535. 10.2215/CJN.06380613 PubMed DOI PMC

Bleyer, A. J. , Kmoch, S. , & Greka, A. (2019). Diagnostic utility of exome sequencing for kidney disease. The New England Journal of Medicine, 380(21), 2080–2081. 10.1056/NEJMc1903250 PubMed DOI

Bleyer, A. J. , Wolf, M. T. , Kidd, K. O. , Zivna, M. , & Kmoch, S. (2021). Autosomal dominant tubulointerstitial kidney disease: More than just HNF1beta. Pediatric Nephrology, 37, 933–946. 10.1007/s00467-021-05118-4 PubMed DOI PMC

Bleyer, A. J. , Woodard, A. S. , Shihabi, Z. , Sandhu, J. , Zhu, H. , Satko, S. G. , … Hart, T. C. (2003). Clinical characterization of a family with a mutation in the uromodulin (Tamm‐Horsfall glycoprotein) gene. Kidney International, 64(1), 36–42. PubMed

Bleyer, A. J. , Zivna, M. , Hulkova, H. , Hodanova, K. , Vyletal, P. , Sikora, J. , … Hart, P. S. (2010). Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone. Clinical Nephrology, 74(6), 411–422. 10.5414/cnp74411 PubMed DOI PMC

Blumenstiel, B. , DeFelice, M. , Birsoy, O. , Bleyer, A. J. , Kmoch, S. , Carter, T. A. , … Lennon, N. J. (2016). Development and validation of a mass spectrometry‐based assay for the molecular diagnosis of Mucin‐1 kidney disease. The Journal of Molecular Diagnostics, 18(4), 566–571. 10.1016/j.jmoldx.2016.03.003 PubMed DOI

Bockenhauer, D. , & Jaureguiberry, G. (2016). HNF1B‐associated clinical phenotypes: The kidney and beyond. Pediatric Nephrology, 31(5), 707–714. 10.1007/s00467-015-3142-2 PubMed DOI

Bolar, N. A. , Golzio, C. , Zivna, M. , Hayot, G. , Van, H. C. , Schepers, D. , … Loeys, B. L. (2016). Heterozygous loss‐of‐function SEC61A1 mutations cause autosomal‐dominant Tubulo‐interstitial and glomerulocystic kidney disease with anemia. American Journal of Human Genetics, 99(1), 174–187. 10.1016/j.ajhg.2016.05.028 PubMed DOI PMC

Bollee, G. , Dahan, K. , Flamant, M. , Moriniere, V. , Pawtowski, A. , Heidet, L. , … Knebelmann, B. (2011). Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clinical Journal of the American Society of Nephrology, 6(10), 2429–2438. 10.2215/CJN.01220211 PubMed DOI PMC

Brown, D. D. , Roem, J. , Ng, D. K. , Reidy, K. J. , Kumar, J. , Abramowitz, M. K. , … Melamed, M. L. (2020). Low serum bicarbonate and CKD progression in children. Clinical Journal of the American Society of Nephrology, 15(6), 755–765. 10.2215/CJN.07060619 PubMed DOI PMC

Brunati, M. , Perucca, S. , Han, L. , Cattaneo, A. , Consolato, F. , Andolfo, A. , … Rampoldi, L. (2015). The serine protease hepsin mediates urinary secretion and polymerisation of zona Pellucida domain protein uromodulin. eLife, 4, e08887. 10.7554/eLife.08887 PubMed DOI PMC

Buglioni, A. , Hasadsri, L. , Nasr, S. H. , Hogan, M. , Moyer, A. , Siddique, K. , … Alexander, M. P. (2021). Mitochondriopathy manifesting as inherited Tubulointerstitial nephropathy without symptomatic other organ involvement. Kidney International Reports, 6(9), 2514–2518. 10.1016/j.ekir.2021.05.042 PubMed DOI PMC

Chatterjee, M. , van Putten, J. P. M. , & Strijbis, K. (2020). Defensive properties of mucin glycoproteins during respiratory infections‐relevance for SARS‐CoV‐2. mBio, 11(6), e02374‐20. 10.1128/mBio.02374-20 PubMed DOI PMC

Clissold, R. L. , Hamilton, A. J. , Hattersley, A. T. , Ellard, S. , & Bingham, C. (2015). HNF1B‐associated renal and extra‐renal disease‐an expanding clinical spectrum. Nature Reviews. Nephrology, 11(2), 102–112. 10.1038/nrneph.2014.232 PubMed DOI

Connaughton, D. M. , Kennedy, C. , Shril, S. , Mann, N. , Murray, S. L. , Williams, P. A. , … Hildebrandt, F. (2019). Monogenic causes of chronic kidney disease in adults. Kidney International, 95(4), 914–928. 10.1016/j.kint.2018.10.031 PubMed DOI PMC

Connor, T. M. , Hoer, S. , Mallett, A. , Gale, D. P. , Gomez‐Duran, A. , Posse, V. , … Maxwell, P. H. (2017). Mutations in mitochondrial DNA causing tubulointerstitial kidney disease. PLoS Genetics, 13(3), e1006620. 10.1371/journal.pgen.1006620 PubMed DOI PMC

Cormican, S. , Connaughton, D. M. , Kennedy, C. , Murray, S. , Zivna, M. , Kmoch, S. , … Conlon, P. J. (2019). Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland. Renal Failure, 41(1), 832–841. 10.1080/0886022X.2019.1655452 PubMed DOI PMC

Cornec‐Le Gall, E. , Olson, R. J. , Besse, W. , Heyer, C. M. , Gainullin, V. G. , Smith, J. M. , … Harris, P. C. (2018). Monoallelic mutations to DNAJB11 cause atypical autosomal‐dominant polycystic kidney disease. American Journal of Human Genetics, 102(5), 832–844. 10.1016/j.ajhg.2018.03.013 PubMed DOI PMC

Devuyst, O. , Olinger, E. , Weber, S. , Eckardt, K. U. , Kmoch, S. , Rampoldi, L. , & Bleyer, A. J. (2019). Autosomal dominant tubulointerstitial kidney disease. Nature Reviews. Disease Primers, 5(1), 60. 10.1038/s41572-019-0109-9 PubMed DOI

Dvela‐Levitt, M. , Kost‐Alimova, M. , Emani, M. , Kohnert, E. , Thompson, R. , Sidhom, E. H. , … Greka, A. (2019). Small molecule targets TMED9 and promotes lysosomal degradation to reverse Proteinopathy. Cell, 178(3), 521–535.e523. 10.1016/j.cell.2019.07.002 PubMed DOI

Edghill, E. L. , Oram, R. A. , Owens, M. , Stals, K. L. , Harries, L. W. , Hattersley, A. T. , … Bingham, C. (2008). Hepatocyte nuclear factor‐1beta gene deletions‐‐a common cause of renal disease. Nephrology, Dialysis, Transplantation, 23(2), 627–635. 10.1093/ndt/gfm603 PubMed DOI

Ekici, A. B. , Hackenbeck, T. , Moriniere, V. , Pannes, A. , Buettner, M. , Uebe, S. , … Wiesener, M. S. (2014). Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney International, 86(3), 589–599. 10.1038/ki.2014.72 PubMed DOI

Faguer, S. , Decramer, S. , Chassaing, N. , Bellanne‐Chantelot, C. , Calvas, P. , Beaufils, S. , … Chauveau, D. (2011). Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney International, 80(7), 768–776. 10.1038/ki.2011.225 PubMed DOI

Gendler, S. , Taylor‐Papadimitriou, J. , Duhig, T. , Rothbard, J. , & Burchell, J. (1988). A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. The Journal of Biological Chemistry, 263(26), 12820–12823. https://www.ncbi.nlm.nih.gov/pubmed/3417635 PubMed

Groopman, E. E. , Marasa, M. , Cameron‐Christie, S. , Petrovski, S. , Aggarwal, V. S. , Milo‐Rasouly, H. , … Gharavi, A. G. (2019). Diagnostic utility of exome sequencing for kidney disease. The New England Journal of Medicine, 380(2), 142–151. 10.1056/NEJMoa1806891 PubMed DOI PMC

Hart, T. C. , Gorry, M. C. , Hart, P. S. , Woodard, A. S. , Shihabi, Z. , Sandhu, J. , … Bleyer, A. J. (2002). Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. Journal of Medical Genetics, 39(12), 882–892. 10.1136/jmg.39.12.882 PubMed DOI PMC

Haumaitre, C. , Fabre, M. , Cormier, S. , Baumann, C. , Delezoide, A. L. , & Cereghini, S. (2006). Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1beta/MODY5 mutations. Human Molecular Genetics, 15(15), 2363–2375. 10.1093/hmg/ddl161 PubMed DOI

Heerspink, H. J. L. , Stefansson, B. V. , Correa‐Rotter, R. , Chertow, G. M. , Greene, T. , Hou, F. F. , … Investigators . (2020). Dapagliflozin in patients with chronic kidney disease. The New England Journal of Medicine, 383(15), 1436–1446. 10.1056/NEJMoa2024816 PubMed DOI

Heidet, L. , Decramer, S. , Pawtowski, A. , Moriniere, V. , Bandin, F. , Knebelmann, B. , … Salomon, R. (2010). Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clinical Journal of the American Society of Nephrology, 5(6), 1079–1090. 10.2215/CJN.06810909 PubMed DOI PMC

Horikawa, Y. , Iwasaki, N. , Hara, M. , Furuta, H. , Hinokio, Y. , Cockburn, B. N. , … Bell, G. I. (1997). Mutation in hepatocyte nuclear factor‐1 beta gene (TCF2) associated with MODY. Nature Genetics, 17(4), 384–385. 10.1038/ng1297-384 PubMed DOI

Huynh, V. T. , Audrezet, M. P. , Sayer, J. A. , Ong, A. C. , Lefevre, S. , Le Brun, V. , … Cornec‐Le Gall, E. (2020). Clinical spectrum, prognosis and estimated prevalence of DNAJB11‐kidney disease. Kidney International, 98(2), 476–487. 10.1016/j.kint.2020.02.022 PubMed DOI PMC

Izzi, C. , Dordoni, C. , Econimo, L. , Delbarba, E. , Grati, F. R. , Martin, E. , … Scolari, F. (2020). Variable expressivity of HNF1B‐nephropathy: From renal cysts and diabetes to medullary sponge kidney through Tubulo‐interstitial kidney disease. Kidney International Reports, 5(12), 2341–2350. PubMed PMC

Kamath, B. M. , Podkameni, G. , Hutchinson, A. L. , Leonard, L. D. , Gerfen, J. , Krantz, I. D. , … Meyers, K. (2012). Renal anomalies in Alagille syndrome: A disease‐defining feature. American Journal of Medical Genetics. Part A, 158A(1), 85–89. 10.1002/ajmg.a.34369 PubMed DOI PMC

Kidd, K. , Vylet'al, P. , Schaeffer, C. , Olinger, E. , Zivna, M. , Hodanova, K. , … Bleyer, A. J. (2020). Genetic and clinical predictors of age of ESKD in individuals with autosomal dominant Tubulointerstitial kidney disease due to UMOD mutations. Kidney Int Rep, 5(9), 1472–1485. 10.1016/j.ekir.2020.06.029 PubMed DOI PMC

Kirby, A. , Gnirke, A. , Jaffe, D. B. , Baresova, V. , Pochet, N. , Blumenstiel, B. , … Daly, M. J. (2013). Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nature Genetics, 45(3), 299–303. 10.1038/ng.2543 PubMed DOI PMC

Kiser, R. L. , Wolf, M. T. F. , Martin, J. L. , Zalewski, I. , Attanasio, M. , Hildebrandt, F. , & Klemmer, P. (2004). Medullary cystic kidney disease type 1 in a large native‐American kindred. American Journal of Kidney Diseases, 44, 611–617. PubMed

Kmoch, S. , Zivna, M. , & Bleyer, A. J. (1993). Autosomal dominant Tubulointerstitial kidney disease‐REN‐Related. https://www.ncbi.nlm.nih.gov/books/NBK53700/. PubMed PMC

Knaup, K. X. , Hackenbeck, T. , Popp, B. , Stoeckert, J. , Wenzel, A. , Buttner‐Herold, M. , … Wiesener, M. S. (2018). Biallelic expression of Mucin‐1 in autosomal dominant Tubulointerstitial kidney disease: Implications for nongenetic disease recognition. Journal of the American Society of Nephrology, 29(9), 2298–2309. 10.1681/ASN.2018030245 PubMed DOI PMC

Kolatsi‐Joannou, M. , Bingham, C. , Ellard, S. , Bulman, M. P. , Allen, L. I. S. , Hattersley, A. T. , & Woolf, A. S. (2001). Hepatocyte nuclear factor ‐1β: A new kindred with renal cysts and diabetes and gene expression in normal human development. Journal of the American Society of Nephrology, 12, 2175–2180. PubMed

Kolbuc, M. , Lessmeier, L. , Salamon‐Slowinska, D. , Malecka, I. , Pawlaczyk, K. , Walkowiak, J. , … Zaniew, M. (2020). Hypomagnesemia is underestimated in children with HNF1B mutations. Pediatric Nephrology, 35(10), 1877–1886. 10.1007/s00467-020-04576-6 PubMed DOI

Kousathanas, A. , Pairo‐Castineira, E. , Rawlik, K. , Stuckey, A. , Odhams, C. A. , Walker, S. , … Baillie, J. K. (2022). Whole‐genome sequencing reveals host factors underlying critical COVID‐19. Nature, 607(7917), 97–103. 10.1038/s41586-022-04576-6 PubMed DOI PMC

Kumar, S. , Cruz, E. , Joshi, S. , Patel, A. , Jahan, R. , Batra, S. K. , & Jain, M. (2017). Genetic variants of mucins: Unexplored conundrum. Carcinogenesis, 38(7), 671–679. 10.1093/carcin/bgw120 PubMed DOI PMC

Lemoine, H. , Raud, L. , Foulquier, F. , Sayer, J. A. , Lambert, B. , Olinger, E. , … Cornec‐Le Gall, E. (2022). Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis. American Journal of Human Genetics, 109(8), 1484–1499. 10.1016/j.ajhg.2022.06.013 PubMed DOI PMC

Lemos, M. C. , & Thakker, R. V. (2020). Hypoparathyroidism, deafness, and renal dysplasia syndrome: 20 years after the identification of the first GATA3 mutations. Human Mutation, 41(8), 1341–1350. 10.1002/humu.24052 PubMed DOI

Lhotta, K. , Piret, S. E. , Kramar, R. , Thakker, R. V. , Sunder‐Plassmann, G. , & Kotanko, P. (2012). Epidemiology of uromodulin‐associated kidney disease ‐ results from a nation‐wide survey. Nephron Extra, 2(1), 147–158. 10.1159/000339102 PubMed DOI PMC

Ligtenberg, M. J. , Gennissen, A. M. , Vos, H. L. , & Hilkens, J. (1991). A single nucleotide polymorphism in an exon dictates allele dependent differential splicing of episialin mRNA. Nucleic Acids Research, 19(2), 297–301. 10.1093/nar/19.2.297 PubMed DOI PMC

Montoli, A. , Colussi, G. , Massa, O. , Caccia, R. , Rizzoni, G. , Civati, G. , & Barbetti, F. (2002). Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor‐1 beta gene: Description of a new family with associated liver involvement. American Journal of Kidney Diseases, 40(2), 397–402. 10.1053/ajkd.2002.34538 PubMed DOI

Mutig, K. , Kahl, T. , Saritas, T. , Godes, M. , Persson, P. , Bates, J. , … Bachmann, S. (2011). Activation of the bumetanide‐sensitive Na+, K+, 2Cl‐ cotransporter (NKCC2) is facilitated by Tamm‐Horsfall protein in a chloride‐sensitive manner 1. Journal of Biological Chemistry, 286(34), 30200–30210. PubMed PMC

Nangaku, M. (2020). More reasons to use SGLT2 inhibitors: EMPEROR‐reduced and DAPA‐CKD. Kidney International, 98(6), 1387–1389. 10.1016/j.kint.2020.10.002 PubMed DOI

Neumann, H. P. H. , Zauner, I. , Strahm, B. , Bender, B. U. , Schollmeyer, P. , Blum, U. , … Hildebrandt, F. (1997). Late occurrence of cysts in autosomal dominant medullary cystic kidney disease. Nephrology, Dialysis, Transplantation, 12, 1242–1246. PubMed

Okorn, C. , Goertz, A. , Vester, U. , Beck, B. B. , Bergmann, C. , Habbig, S. , … Weber, S. (2019). HNF1B nephropathy has a slow‐progressive phenotype in childhood‐with the exception of very early onset cases: Results of the German multicenter HNF1B childhood registry. Pediatric Nephrology, 34(6), 1065–1075. 10.1007/s00467-018-4188-8 PubMed DOI

Olinger, E. , Hofmann, P. , Kidd, K. , Dufour, I. , Belge, H. , Schaeffer, C. , … Devuyst, O. (2020). Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney International, 98(3), 717–731. 10.1016/j.kint.2020.04.038 PubMed DOI

Olinger, E. , Schaeffer, C. , Kidd, K. , Elhassan, E. A. E. , Cheng, Y. , Dufour, I. , … Devuyst, O. (2022). An intermediate‐effect size variant in UMOD confers risk for chronic kidney disease. Proceedings of the National Academy of Sciences of the United States of America, 119(33), e2114734119. 10.1073/pnas.2114734119 PubMed DOI PMC

Patton, S. , Gendler, S. J. , & Spicer, A. P. (1995). The epithelial mucin, MUC1, of milk, mammary gland and other tissues 1. Biochimica et Biophysica Acta, 1241(3), 407–423. PubMed

Pisani, I. , Allinovi, M. , Palazzo, V. , Zanelli, P. , Gentile, M. , Farina, M. T. , … Manenti, L. (2022). More dissimilarities than affinities between DNAJB11‐PKD and ADPKD. Clinical Kidney Journal, 15(6), 1179–1187. 10.1093/ckj/sfac032 PubMed DOI PMC

Pottel, H. , Bjork, J. , Bokenkamp, A. , Berg, U. , Asling‐Monemi, K. , Selistre, L. , … Delanaye, P. (2019). Estimating glomerular filtration rate at the transition from pediatric to adult care. Kidney International, 95(5), 1234–1243. 10.1016/j.kint.2018.12.020 PubMed DOI

Rampoldi, L. , Scolari, F. , Amoroso, A. , Ghiggeri, G. , & Devuyst, O. (2011). The rediscovery of uromodulin (Tamm‐Horsfall protein): From tubulointerstitial nephropathy to chronic kidney disease. Kidney International, 80(4), 338–347. 10.1038/ki.2011.134 PubMed DOI

Reardon, W. , Casserly, L. F. , Birkenhager, R. , & Kohlhase, J. (2007). Kidney failure in Townes‐brocks syndrome: An under recognized phenomenon? American Journal of Medical Genetics. Part A, 143A(21), 2588–2591. 10.1002/ajmg.a.31699 PubMed DOI

Renigunta, A. , Renigunta, V. , Saritas, T. , Decher, N. , Mutig, K. , & Waldegger, S. (2011). Tamm‐Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function 1. Journal of Biological Chemistry, 286(3), 2224–2235. PubMed PMC

Saleh, M. , Kamath, B. M. , & Chitayat, D. (2016). Alagille syndrome: Clinical perspectives. The Application of Clinical Genetics, 9, 75–82. 10.2147/TACG.S86420 PubMed DOI PMC

Schaeffer, C. , Izzi, C. , Vettori, A. , Pasqualetto, E. , Cittaro, D. , Lazarevic, D. , … Rampoldi, L. (2019). Autosomal dominant Tubulointerstitial kidney disease with adult onset due to a novel renin mutation mapping in the mature protein. Scientific Reports, 9(1), 11601. 10.1038/s41598-019-48014-6 PubMed DOI PMC

Scolari, F. , Caridi, G. , Rampoldi, L. , Tardanico, R. , Izzi, C. , Pirulli, D. , … Ghiggeri, G. M. (2004). Uromodulin storage diseases: Clinical aspects and mechanisms. American Journal of Kidney Diseases, 44(6), 987–999. PubMed

Senum, S. R. , Li, Y. S. M. , Benson, K. A. , Joli, G. , Olinger, E. , Lavu, S. , … Harris, P. C. (2022). Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney‐spectrum phenotype. American Journal of Human Genetics, 109(1), 136–156. 10.1016/j.ajhg.2021.11.016 PubMed DOI PMC

Serafini‐Cessi, F. , Bellabarba, G. , Malagolini, N. , & Dall'Olio, F. (1989). Rapid isolation of Tamm‐Horsfall glycoprotein (uromodulin) from human urine. Journal of Immunological Methods, 120(2), 185–189. PubMed

Serafini‐Cessi, F. , Malagolini, N. , Hoops, T. C. , & Rindler, M. J. (1993). Biosynthesis and oligosaccharide processing of human Tamm‐Horsfall glycoprotein permanently expressed in HeLa cells. Biochemical and Biophysical Research Communications, 194(2), 784–790. PubMed

Smith, G. D. , Robinson, C. , Stewart, A. P. , Edwards, E. L. , Karet, H. I. , Norden, A. G. , … Karet Frankl, F. E. (2011). Characterization of a recurrent in‐frame UMOD indel mutation causing late‐onset autosomal dominant end‐stage renal failure. Clinical Journal of the American Society of Nephrology, 6(12), 2766–2774. 10.2215/CJN.06820711 PubMed DOI PMC

Spinner, N. B. , Gilbert, M. A. , Loomes, K. M. , & Krantz, I. D. (1993). Alagille Syndrome. In Adam M. P., Ardinger H. H., Pagon R. A., Wallace S. E., Bean L. J. H., Mirzaa G., & Amemiya A. (Eds.), GeneReviews([R]). Seattle, WA: University of Washington, Seattle. PubMed

Stavrou, C. , Koptides, M. , Tombazos, C. , Psara, E. , Patsias, C. , Zouvani, I. , … Deltas, C. C. (2002). Autosomal‐dominant medullary cystic kidney disease type 1: Clinical and molecular findings in six large Cypriot families. Kidney International, 62(4), 1385–1394. 10.1111/j.1523-1755.2002.kid581.x PubMed DOI

Table C.11 Patient Counts: by Detailed Primary Diagnosis . (2000). In National Institute of Diabetes and Digestive and Kidney Diseases (Ed.), USRDS 2000 annual data report: Atlas of end‐stage renal disease in the United States (pp. 377–388). (Reprinted from Not in File).

Upadhyay, J. , Steenkamp, D. W. , & Milunsky, J. M. (2013). The syndrome of hypoparathyroidism, deafness, and renal anomalies. Endocrine Practice, 19(6), 1035–1042. PubMed

Vylet'al, P. , Kidd, K. , Ainsworth, H. C. , Springer, D. , Vrbacka, A. , Pristoupilova, A. , … Bleyer, A. J. (2021). Plasma Mucin‐1 (CA15‐3) levels in autosomal dominant Tubulointerstitial kidney disease due to MUC1 mutations. American Journal of Nephrology, 52(5), 378–387. 10.1159/000515810 PubMed DOI PMC

Vylet'al, P. , Kublova, M. , Kalbacova, M. , Hodanova, K. , Baresova, V. , Stiburkova, B. , … Kmoch, S. (2006). Alterations of uromodulin biology: A common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney International, 70(6), 1,155–1,169. PubMed

Vyletal, P. , Bleyer, A. J. , & Kmoch, S. (2010). Uromodulin biology and pathophysiology‐‐an update. Kidney and Blood Pressure Research, 33(6), 456–475. 10.1159/000321013 PubMed DOI

Warren, D. J. , Simmonds, H. A. , Gibson, T. , & Naik, R. B. (1981). Familial gout and renal failure. Archives of Disease in Childhood, 56, 699–704. PubMed PMC

Weiss, G. L. , Stanisich, J. J. , Sauer, M. M. , Lin, C.‐W. , Eras, J. , Zyla, D. S. , … Glockshuber, R. (2020). Architecture and function of human uromodulin filaments in urinary tract infections. Science, 369(6506), 1,005–1,010. 10.1126/science.aaz9866 PubMed DOI

Wenzel, A. , Altmueller, J. , Ekici, A. B. , Popp, B. , Stueber, K. , Thiele, H. , … Beck, B. B. (2018). Single molecule real time sequencing in ADTKD‐MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations. Scientific Reports, 8(1), 4,170. 10.1038/s41598-018-22428-0 PubMed DOI PMC

Wolf, M. T. (2015). Nephronophthisis and related syndromes. Current Opinion in Pediatrics, 27(2), 201–211. 10.1097/MOP.0000000000000194 PubMed DOI PMC

Wolf, M. T. , & Hildebrandt, F. (2011). Nephronophthisis. Pediatric Nephrology, 26(2), 181–194. 10.1007/s00467-010-1585-z PubMed DOI PMC

Wopperer, F. J. , Knaup, K. X. , Stanzick, K. J. , Schneider, K. , Jobst‐Schwan, T. , Ekici, A. B. , … Wiesener, M. S. (2022). Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases. Kidney International, 102(2), 405–420. 10.1016/j.kint.2022.04.031 PubMed DOI

Yamamoto, S. , Kaimori, J. Y. , Yoshimura, T. , Namba, T. , Imai, A. , Kobayashi, K. , … Isaka, Y. (2017). Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein. Nephrology Dialysis Transplantation, 32(12), 2010–2017. 10.1093/ndt/gfx083 PubMed DOI

Zaucke, F. , Boehnlein, J. M. , Steffens, S. , Polishchuk, R. S. , Rampolid, L. , Fischer, A. , … Wolf, M. T. (2010). Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression. Human Molecular Genetics, 19(10), 1985–1997. PubMed PMC

Zhang, L. , Vlad, A. , Milcarek, C. , & Finn, O. J. (2013). Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms. Cancer Immunology, Immunotherapy, 62(3), 423–435. 10.1007/s00262-012-1325-2 PubMed DOI PMC

Zivna, M. , Hulkova, H. , Matignon, M. , Hodanova, K. , Vylet'al, P. , Kalbacova, M. , … Kmoch, S. (2009). Dominant renin gene mutations associated with early‐onset hyperuricemia, anemia, and chronic kidney failure. American Journal of Human Genetics, 85(2), 204–213. 10.1016/j.ajhg.2009.07.010 PubMed DOI PMC

Zivna, M. , Kidd, K. , Pristoupilova, A. , Baresova, V. , DeFelice, M. , Blumenstiel, B. , … Kmoch, S. (2018). Noninvasive Immunohistochemical diagnosis and novel MUC1 mutations causing autosomal dominant Tubulointerstitial kidney disease. Journal of the American Society of Nephrology, 29(9), 2,418–2,431. 10.1681/Asn.2018020180 PubMed DOI PMC

Zivna, M. , Kidd, K. , Zaidan, M. , Vyletal, P. , Baresova, V. , Hodanova, K. , … Bleyer, A. J. (2020). An international cohort study of autosomal dominant Tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes. Kidney International, 98(6), 1589–1604. 10.1016/j.kint.2020.06.041 PubMed DOI PMC

Eight-fold increased COVID-19 mortality in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations: an observational study

Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors

A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis